The Impact of Orthopaedic Smoking Cessation Education on Cigarette Abstinence Self-Efficacy: A Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02408809

Enrollment

Registered

2015-04-03

Start date

2015-03-31

Completion date

2016-04-30

Last updated

2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

Orthopaedic Smoking Cessation Discussion, Smoking Cessation, Randomized Controlled Trial

Brief summary

The investigators of this study aim to evaluate the impact of a new orthopaedic related smoking cessation discussion on smoking behavior. Considering the high prevalence of patients who smoke and receive orthopaedic management, we are interested in determining whether an orthopaedic smoking cessation discussion impacts smoking abstinence self-efficacy over time compared to a general smoking cessation discussion.

Interventions

BEHAVIORALGeneral Smoking Cessation Discussion

This group receives the 5 A's of smoking cessation counseling incorporating how cigarette smoking negatively impacts general health (cancer, MI). 10 minutes in length.

BEHAVIORALOrthopaedic Related Smoking Cessation Discussion

The participants in this group receive a discussion including the 5 A's of smoking cessation counseling incorporating an orthopaedic related smoking cessation discussion about the effects of smoking cigarettes on the musculoskeletal system. 10 minutes in length.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Daily cigarette smokers (5 cigarettes or more a day for past year), 18 years of age or older, new orthopaedic management, native English speaker

Exclusion criteria

* Patients unable to provide consent, suffer an impairment (mental, psychiatric, hearing or sight), alcohol and illicit drug abusers, homeless, presently managed with a smoking cessation medication or counseling, living with a cigarette smoker, user of other tobacco products

Design outcomes

Primary

Measure	Time frame	Description
SASEQ	5 minutes	Smoking abstinence Self-Efficacy Questionnaire

Secondary

Measure	Time frame	Description
Patient Knowledge and Motivation to Quit	less than 20 minutes	Knowledge and Motivation assessments

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026